SANUWAVE Health, Inc. (NASDAQ:SNWV - Get Free Report) COO Peter Stegagno sold 1,862 shares of the stock in a transaction dated Thursday, June 5th. The shares were sold at an average price of $27.71, for a total transaction of $51,596.02. Following the completion of the transaction, the chief operating officer now directly owns 2,032 shares in the company, valued at approximately $56,306.72. This represents a 47.82% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
SANUWAVE Health Stock Performance
NASDAQ SNWV traded up $2.25 on Monday, reaching $30.16. The stock had a trading volume of 81,825 shares, compared to its average volume of 34,038. The stock's fifty day moving average is $29.54. SANUWAVE Health, Inc. has a 1-year low of $5.17 and a 1-year high of $39.50. The stock has a market capitalization of $258.05 million, a P/E ratio of -6.61 and a beta of 1.19.
SANUWAVE Health (NASDAQ:SNWV - Get Free Report) last announced its earnings results on Friday, May 9th. The company reported ($0.66) earnings per share (EPS) for the quarter. The firm had revenue of $9.34 million for the quarter.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently made changes to their positions in SNWV. Strategic Investment Solutions Inc. IL acquired a new stake in shares of SANUWAVE Health in the first quarter valued at approximately $47,000. Goldman Sachs Group Inc. bought a new position in SANUWAVE Health during the 1st quarter worth $337,000. AWM Investment Company Inc. acquired a new position in SANUWAVE Health in the 1st quarter valued at $18,153,000. Finally, Solas Capital Management LLC acquired a new stake in SANUWAVE Health during the first quarter worth about $20,658,000. Institutional investors and hedge funds own 42.53% of the company's stock.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen downgraded SANUWAVE Health from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th.
Get Our Latest Report on SANUWAVE Health
About SANUWAVE Health
(
Get Free Report)
SANUWAVE Health, Inc, a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider SANUWAVE Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SANUWAVE Health wasn't on the list.
While SANUWAVE Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
